Sysmex Corporation

Symbol: SSMXF




Market price today

  • 36.9955

    P/E Ratio

  • 0.0631

    PEG Ratio

  • 10.68B

    MRK Cap

  • 0.00%

    DIV Yield

Sysmex Corporation (SSMXF) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO:Mr. Hisashi Ietsugu
Full-time employees:9500
Address:1-5-1 Wakinohama-kaigandori

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services. Further, the company is involved in the development and sale of software for diagnostic information systems; provision of facility management, office, welfare, and genetic analysis services; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. Additionally, it researches, develops, manufactures, and sells regenerative medicine products; develops, manufactures, and sells biodevices; develops, maintains, and sells computer software; and offers blood DNA testing service. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

General Outlook

When we look at how much money they make before expenses, they keep 0.532% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.165%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.103%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.079% return, is a testament to Sysmex Corporation's adeptness in optimizing resource deployment. Sysmex Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.112%. Furthermore, the proficiency of Sysmex Corporation in capital utilization is underscored by a remarkable 0.154% return on capital employed.

Stock Prices

Sysmex Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $58.96, while its low point bottomed out at $58.96. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Sysmex Corporation's stock market.

Liquidity Ratios

Analyzing SSMXF liquidity ratios reveals its financial health of the firm. The current ratio of 309.65% gauges short-term asset coverage for liabilities. The quick ratio (197.18%) assesses immediate liquidity, while the cash ratio (60.27%) indicates cash reserves.

Current Ratio309.65%
Quick Ratio197.18%
Cash Ratio60.27%

Profitability Ratios

SSMXF profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 16.04% underscores its earnings before tax deductions. The effective tax rate stands at 33.63%, revealing its tax efficiency. The net income per EBT, 64.08%, and the EBT per EBIT, 97.44%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 16.46%, we grasp its operational profitability.

Pretax Profit Margin16.04%
Effective Tax Rate33.63%
Net Income per EBT64.08%
EBT per EBIT97.44%
EBIT per Revenue16.46%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 3.10, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 328.28% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

Days of Sales Outstanding197
Days of Inventory Outstanding145
Operating Cycle256.49
Days of Payables Outstanding46
Cash Conversion Cycle210
Receivables Turnover3.28
Payables Turnover7.86
Inventory Turnover2.51
Fixed Asset Turnover3.95
Asset Turnover0.77

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 108.38, and free cash flow per share, 28.12, depict cash generation on a per-share basis. The cash per share value, 96.99, showcases liquidity position. A payout ratio of 0.39 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.15, offers insight into cash flow relative to sales.

Operating Cash Flow per Share108.38
Free Cash Flow per Share28.12
Cash per Share96.99
Payout Ratio0.39
Operating Cash Flow Sales Ratio0.15
Free Cash Flow to Operating Cash Flow Ratio0.26
Cash Flow Coverage Ratio2.06
Short Term Coverage Ratio8.64
Capital Expenditure Coverage Ratio1.35
Dividend Paid and Capex Coverage Ratio1.00

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 5.79%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.08, we discern the balance between debt and equity financing. The long-term debt to capitalization, 5.80%, and total debt to capitalization, 7.48%, ratios shed light on its capital structure. An interest coverage of 37.22 indicates its ability to manage interest expenses.

Debt Ratio5.79%
Debt Equity Ratio0.08
Long Term Debt to Capitalization5.80%
Total Debt to Capitalization7.48%
Interest Coverage37.22
Cash Flow to Debt Ratio2.06
Company Equity Multiplier1.40

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 654.00, provides a glimpse into top-line earnings distributed across each share. Net income per share, 72.94, reflects the portion of profit attributed to each share. The book value per share, 617.61, represents the net asset value distributed per share, while the tangible book value per share, 474.74, excludes intangible assets.

Revenue Per Share654.00
Net Income Per Share72.94
Book Value Per Share617.61
Tangible Book Value Per Share474.74
Shareholders Equity Per Share617.61
Interest Debt Per Share38.49
Capex Per Share-67.72

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 12.84%, indicates top-line expansion, while the gross profit growth, 13.38%, reveals profitability trends. EBIT growth, 9.29%, and operating income growth, 9.29%, offer insights into operational profitability progression. The net income growth, 3.84%, showcases bottom-line expansion, and the EPS growth, 3.77%, measures the growth in earnings per share.

Revenue Growth12.84%
Gross Profit Growth13.38%
EBIT Growth9.29%
Operating Income Growth9.29%
Net Income Growth3.84%
EPS Growth3.77%
EPS Diluted Growth3.92%
Weighted Average Shares Growth0.07%
Weighted Average Shares Diluted Growth-0.07%
Dividends per Share Growth8.25%
Operating Cash Flow Growth17.19%
Free Cash Flow Growth-1.40%
10-Year Revenue Growth per Share-7.49%
5-Year Revenue Growth per Share-51.68%
3-Year Revenue Growth per Share35.63%
10-Year Operating CF Growth per Share-12.49%
5-Year Operating CF Growth per Share-56.27%
3-Year Operating CF Growth per Share29.14%
10-Year Net Income Growth per Share6.04%
5-Year Net Income Growth per Share-61.26%
3-Year Net Income Growth per Share30.96%
10-Year Shareholders Equity Growth per Share6.74%
5-Year Shareholders Equity Growth per Share-46.56%
3-Year Shareholders Equity Growth per Share39.29%
10-Year Dividend per Share Growth per Share46.43%
5-Year Dividend per Share Growth per Share-56.09%
3-Year Dividend per Share Growth per Share9.73%
Receivables Growth6.51%
Inventory Growth18.35%
Asset Growth9.79%
Book Value per Share Growth11.23%
Debt Growth1.40%
R&D Expense Growth15.96%
SGA Expenses Growth19.25%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 5,110,897,595,241.005, captures the company's total value, considering both debt and equity. Income quality, 1.00, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.27, gauges operational efficiency, while the research and development to revenue, 7.57%, highlights investment in innovation. The ratio of intangibles to total assets, 17.02%, indicates the value of non-physical assets, and capex to operating cash flow, -61.75%, measures reinvestment capability.

Enterprise Value5,110,897,595,241.005
Income Quality1.00
Sales General and Administrative to Revenue0.27
Research and Development to Revenue7.57%
Intangibles to Total Assets17.02%
Capex to Operating Cash Flow-61.75%
Capex to Revenue-10.35%
Capex to Depreciation-133.63%
Graham Number1006.79
Return on Tangible Assets10.39%
Graham Net Net94.73
Working Capital184,389,000,000
Tangible Asset Value297,984,000,000
Net Current Asset Value152,773,000,000
Average Receivables123,043,000,000
Average Payables31,894,500,000
Average Inventory67,627,000,000
Days Sales Outstanding113
Days Payables Outstanding59
Days of Inventory On Hand138

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 4.10, and the price to book ratio, 4.10, reflect the market's valuation relative to the company's book value. The price to sales ratio, 3.79, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 94.37, and price to operating cash flows, 24.58, gauge market valuation against cash flow metrics.

Price Book Value Ratio4.10
Price to Book Ratio4.10
Price to Sales Ratio3.79
Price Cash Flow Ratio24.58
Price Earnings to Growth Ratio0.06
Enterprise Value Multiple15.83
Price Fair Value4.10
Price to Operating Cash Flow Ratio24.58
Price to Free Cash Flows Ratio94.37
Price to Tangible Book Ratio13.30
Enterprise Value to Sales12.45
Enterprise Value Over EBITDA48.93
EV to Operating Cash Flow74.25
Earnings Yield0.89%
Free Cash Flow Yield0.51%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Sysmex Corporation (SSMXF) on the PNK in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 36.995 in 2024.

What is the ticker symbol of Sysmex Corporation stock?

The ticker symbol of Sysmex Corporation stock is SSMXF.

What is company IPO date?

IPO date of Sysmex Corporation is 2009-04-21.

What is company current share price?

Current share price is 17.126 USD.

What is stock market cap today?

The market cap of stock today is 10677494575.000.

What is PEG ratio in 2024?

The current 0.063 is 0.063 in 2024.

What is the number of employees in 2024?

In 2024 the company has 9500.